The U.S. over-the-counter (OTC) drugs market is witnessing steady growth driven by rising self-medication trends, expanding consumer health awareness, and easy access to non-prescription treatments, reaching USD 30.09 billion by 2035 at a CAGR of 5.60%.

U.S. Over the Counter (OTC) Drugs Market Statical Scope

OTC drugs are recognized for their safety and efficacy, having been approved by the U.S. Food and Drug Administration (FDA) and other health authorities worldwide. These medications are employed in the treatment of conditions such as the common cold, pain, allergies, and other minor ailments. The anticipated growth in demand for self-medication and the increasing number of drug approvals are expected to further propel the growth of the U.S. OTC drugs market in the future. Prominent players in the U.S. market are focusing on strategic acquisitions to expand their OTC offerings while ensuring the delivery of high-quality, affordable medications to consumers.

U.S. Over the Counter (OTC) Drugs Market Share, By Product Type, 2025 (%)

• Analgesics- Analgesics lead the segment, with a share of 27%, driven by consistent consumer demand for pain relief solutions used in headaches, body pain, and chronic pain conditions.
• Cold & Cough Remedies- Cold & cough remedies hold a significant share of 22%, supported by frequent seasonal illnesses, prevalence of respiratory infections, and easy OTC accessibility.
• Skin Treatment- Skin treatment products hold a share of 19%, driven by demand for OTC solutions addressing minor skin conditions, infections, and dermatological care.
• Vitamins & Minerals- Vitamins & minerals account for a notable 18% share, driven by rising health consciousness, preventive healthcare, and growing use of dietary supplements.
• Digestives & Intestinal Remedies- Digestives & intestinal remedies represent a share of 14%, supported by growing lifestyle-related digestive issues and demand for OTC gastrointestinal relief products.

U.S. Over the Counter (OTC) Drugs Market Share, By Distribution Channel, 2025 (%)

• Drug Stores & Retail Pharmacies- Drug stores & retail pharmacies dominate the segment, with a share of 58%, driven by strong consumer trust and immediate purchase availability of OTC medicines.
• Online Pharmacies- Online Pharmacies hold a share of 30%, supported by increasing digital adoption, the convenience of home delivery, and the rise of mobile app-based purchasing.
• Hospital Pharmacies- Hospital pharmacies account for a share of 12%, primarily driven by post-treatment OTC dispensing and institutional healthcare usage.

Top Companies in the U.S. Over the Counter (OTC) Drugs Market

• Johnson & Johnson Services Inc.
• Bayer AG
• Novartis AG
• Sanofi S.A.
• Pfizer
• GlaxoSmithKline Plc
• Boehringer Ingelheim International GmbH
• Reckitt Benckiser Group PLC
• Takeda Pharmaceutical Company Ltd.
• Perrigo Company plc

Segments Covered in the Report

By Product Type

• Analgesics
• Cold & Cough Remedies
• Digestives & Intestinal Remedies
• Skin Treatment
• Vitamins & Minerals
• Others

By Distribution Channel

• Drug Stores & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies